Meghan Fitzgerald - Apr 20, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Director
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Meghan FitzGerald
Stock symbol: ROIV
Transactions as of: Apr 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/24/2023, 09:28 PM
Previous filing: Mar 16, 2023
Next filing: Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ROIV	Stock Option (Right to Buy)	Award	$0	+119K		$0.00	119K	Apr 20, 2023	Common Shares	119K	$8.80	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.

Content

Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.